Amgen

AMGN

335.22
USD
2.78
(0.84%)
Market Closed
Volume
96,438
EPS
0
Div Yield
0
P/E
55
Market Cap
170,172,163,974

Related Instruments

ABBV
4.380
(2.36%)
189.700 USD
B
BIIB
-2.500
(-1.17%)
210.710 USD
BMY
0.620
(1.30%)
48.180 USD
GILD
0.470
(0.62%)
76.510 USD
GSK
0.865
(2.23%)
39.650 USD
JNJ
2.930
(1.86%)
160.770 USD
LLY
28.47
(3.54%)
832.74 USD
MRK
0.680
(0.60%)
113.800 USD
NVS
0.650
(0.58%)
112.100 USD
PFE
0.115
(0.38%)
30.650 USD
REGN
13.14
(1.22%)
1,091.19 USD

News

Title: Amgen

Sector: Healthcare
Industry: Drug Manufacturers - General
Amgen Inc. is an American global biopharmaceutical company that engages in the development, manufacture and marketing of human therapeutics. It is headquartered in Thousand Oaks, California. The company has deep interests in molecular biology and biochemistry, which underpin its goal to provide human care based on recombinant DNA technology. Some of the company’s best-performing products include Neulasta and Enbrel. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980.